CTC Netherlands B.V.
- Address
- Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Immune System Diseases
The laboratory at CTC Netherlands B.V. conducts studies on disorders of the immune system, seeking to evaluate the safety and tolerability of emerging therapeutic candidates.
- Celiac disease
- Eosinophilic esophagitis
Ongoing trials aim to characterize pharmacokinetic profiles and improve diagnostic approaches for these conditions, supporting the development of more effective treatments.
Nervous System Diseases
Research at the site addresses challenges in the nervous system, with a particular focus on early-stage neurodegenerative disorders.
- Alzheimer’s Disease
The studies evaluate safety, tolerability, and pharmacodynamic effects of novel agents, aiming to advance therapeutic options for patients with cognitive decline.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CTC Netherlands B.V.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of LIB-01 Monohydrate for Safety and Efficacy in Erectile Dysfunction: A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial | Dicot AB | Phase II | Not Recruiting | Nov 2024 | Aug 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lib-01 Monohydrate | 1 | Unknown | 2024-11-07 | 2024-11-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.